BioMitral Mitralklappenersatz

Klinikpreis auf Anfrage

Produktinformation

Datenblatt

Musci, et al.,”Further Experience with the “No-React” Bioprosthesis in Patients with Active Infective Endocarditis:
11-Year Single Center Results in 402 Patients“, The Thoracic cardiovascular Surgeon 2013; 61(05): 398-408.
Germing, et al., “Patient-prosthesis mismatch and left ventricular remodeling after implantation of Shelhigh SuperStentless aortic valve prostheses”, Journal of Cardiovascular Surgery 2008:49:539-43.
Cattaneo, et al., “Early Hemodynamic Results of the Shelhigh SuperStentless Aortic Bioprostheses“, Journal of Cardiac Surgery 2007; 22:379-384.
Siniawski, et al., "Factors Influencing the Results of Double-Valve Surgery in Patients with Fulminant Endocarditis: The Importance of Valve Selection," The Heart Surgery Forum #2004. 2004; 67(5): 1075.
Akar, et. al., “Use of Stentless Xenografts in the Aortic Position: Determinants of Early and Late Outcome”,
The Annals of Thoracic Surgery 2002; 74: 1450-1457.